We are live on !
Find out more
Lipe & Dalton Portfolio holdings
AUM
$216M
Turnover
8.16%
1-Year Est. Return
27.72%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+27.72%
3 Year Est. Return
+101.25%
5 Year Est. Return
+114.93%
10 Year Est. Return
+404.36%
AUM
$216M
AUM Growth
+$1.03M
(+0.48%)
Cap. Flow
+$1.73M
Cap. Flow % of AUM
Cap. Flow %
0.8%
Top 10 Holdings %
Top 10 Hldgs %
44.06%
Holding
98
New
4
Increased
13
Reduced
16
Closed
4
Avg Time Held
6.7
years
Top 10 Avg Time Held
3.4
years
Top 20 Avg Time Held
5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Leidos
LDOS
|
+$3.34M |
| 2 |
Uber
UBER
|
+$1.22M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$1.05M |
| 4 |
Baxter International
BAX
|
+$111K |
| 5 |
Danaher
DHR
|
+$61.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jack Henry & Associates
JKHY
|
+$2.58M |
| 2 |
CVS Health
CVS
|
+$541K |
| 3 |
Lam Research
LRCX
|
+$130K |
| 4 |
BorgWarner
BWA
|
+$104K |
| 5 |
Intel
INTC
|
+$102K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 19.61% |
| 3 | Industrials | 17.49% |
| 4 | Healthcare | 15.07% |
| 5 | Communication Services | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
26
Leidos
LDOS
$18.1B
| $3.25M | 1.51% |
+26,713
| New | +$3.34M |
2026 Q3
0 quarters
|
|
27
Oneok
OKE
$58.3B
| $3.12M | 1.44% |
36,530
| – | – |
2020 Q2
25 quarters
|
|
28
Amgen
AMGN
$252B
| $3.11M | 1.44% |
7,377
-50
| -0.7% | -$19.9K |
2019 Q1
30 quarters
|
|
29
TC Energy
TRP
$66.3B
| $2.89M | 1.34% |
50,022
| – | – |
2014 Q4
47 quarters
|
|
30
Microsoft
MSFT
$3.77T
| $2.87M | 1.33% |
5,603
-50
| -0.9% | -$23.1K |
2013 Q2
53 quarters
|
|
31
LyondellBasell Industries
LYB
$21.6B
| $2.41M | 1.12% |
41,970
+500
| +1% | +$30.6K |
2015 Q2
45 quarters
|
|
32
Visa
V
$795B
| $2.29M | 1.06% |
6,363
-100
| -2% | -$36.6K |
2015 Q4
43 quarters
|
|
33
Johnson & Johnson
JNJ
$651B
| $2.14M | 0.99% |
8,093
+1
| +0% | +$264 |
2013 Q2
53 quarters
|
|
34
Lockheed Martin
LMT
$149B
| $2.14M | 0.99% |
4,200
+20
| +0.5% | +$11K |
2021 Q4
19 quarters
|
|
35
F5
FFIV
$18.4B
| $2.04M | 0.94% |
4,580
| – | – |
2024 Q3
8 quarters
|
|
36
Vertex Pharmaceuticals
VRTX
$140B
| $1.97M | 0.91% |
3,761
| – | – |
2020 Q4
23 quarters
|
|
37
Martin Marietta Materials
MLM
$39.2B
| $1.9M | 0.88% |
3,963
| – | – |
2018 Q1
34 quarters
|
|
38
Meta Platforms (Facebook)
META
$1.58T
| $1.85M | 0.86% |
2,554
| – | – |
2019 Q2
29 quarters
|
|
39
Brookfield Asset Management
BAM
$82.2B
| $1.78M | 0.82% |
39,965
-126
| -0.3% | -$6.15K |
2022 Q4
15 quarters
|
|
|
40
CVS Health
CVS
$113B
| $1.57M | 0.73% |
18,340
-5,530
| -23% | -$541K |
2013 Q2
53 quarters
|
|
41
Merck
MRK
$366B
| $1.44M | 0.66% |
9,888
+5
| +0.1% | +$691 |
2016 Q4
39 quarters
|
|
42
Jacobs Solutions
J
$18.8B
| $1.34M | 0.62% |
9,904
-375
| -4% | -$52.4K |
2018 Q1
34 quarters
|
|
43
Cigna
CI
$78B
| $1.21M | 0.56% |
4,439
+2
| +0% | +$564 |
2015 Q4
43 quarters
|
|
44
Wells Fargo
WFC
$258B
| $1.19M | 0.55% |
14,838
| – | – |
2020 Q2
25 quarters
|
|
|
45
Uber
UBER
$136B
| $1.14M | 0.53% |
+16,673
| New | +$1.22M |
2026 Q3
0 quarters
|
|
46
Oracle
ORCL
$361B
| $1.02M | 0.47% |
7,421
| – | – |
2013 Q2
53 quarters
|
|
47
NVIDIA
NVDA
$4.88T
| $902K | 0.42% |
3,951
| – | – |
2020 Q2
25 quarters
|
|
48
Carrier Global
CARR
$45.1B
| $766K | 0.35% |
13,965
+3
| +0% | +$186 |
2020 Q2
25 quarters
|
|
49
Verizon
VZ
$187B
| $765K | 0.35% |
16,683
| – | – |
2013 Q2
53 quarters
|
|
50
Booking.com
BKNG
$116B
| $758K | 0.35% |
4,650
| – | – |
2026 Q1
2 quarters
|
|
Similar funds
PCMK
Lipe & Dalton's Q3 2026 Portfolio in Review
As of Q3 2026, Lipe & Dalton held 98 positions worth $216M, up 0.48% from $215M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Lipe & Dalton's Q3 2026 filing shows 4 new, 13 increased, 16 reduced and 4 closed positions. Its largest new stake was Leidos: 26,713 shares worth $3.25M. The largest sale was Jack Henry & Associates, an estimated $2.58M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Lipe & Dalton's largest Q3 2026 buy was Leidos: 26,713 shares worth $3.25M.
- Lipe & Dalton added most to Berkshire Hathaway Class B in Q3 2026, an estimated $1.05M increase.
- Lipe & Dalton's biggest Q3 2026 reduction was CVS Health, cutting an estimated $541K.
- Lipe & Dalton fully exited Jack Henry & Associates in Q3 2026, selling an estimated $2.58M.
- Lipe & Dalton's ten largest holdings make up 44% of its $216M portfolio in Q3 2026.
- Lipe & Dalton opened 4 new positions and closed 4 in Q3 2026.
- Lipe & Dalton's portfolio value rose 0.48% quarter-over-quarter to $216M.
Based on Lipe & Dalton's 13F filing for Q3 2026, filed 15 Oct 2026.